Shanghai Henlius Biotech, Inc. (HKG:2696)

Hong Kong · Delayed Price · Currency is HKD

71.70

+5.70 (8.64%)

At close: Mar 27, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Pharmaceuticals	6.67B	5.72B	5.39B	3.21B	1.68B
Pharmaceuticals Growth	16.46%	6.11%	67.82%	91.07%	186.34%
Total	6.67B	5.72B	5.39B	3.21B	1.68B
Total Growth	16.46%	6.11%	67.82%	91.07%	186.34%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Mainland China	5.78B	5.05B	4.81B	2.84B	1.52B
Mainland China Growth	14.58%	4.89%	69.35%	87.42%	232.77%
Asia Pacific (Excluding Mainland China)	116.01M	236.86M	193.99M	178.97M	57.29M
Asia Pacific (Excluding Mainland China) Growth	-51.02%	22.10%	8.39%	212.42%	187.75%
North America	465.47M	329.12M	314.79M	145.06M	-
North America Growth	41.43%	4.55%	117.01%	-	-
South America	27.58M	10.62M	19.14M	-	-
South America Growth	159.58%	-44.50%	-	-	-
Europe	275.80M	101.41M	56.37M	50.14M	109.54M
Europe Growth	171.96%	79.91%	12.43%	-54.23%	-2.37%
Oceania	-	325.00K	-	-	-
Total	6.67B	5.72B	5.39B	3.21B	1.68B
Total Growth	16.46%	6.11%	67.82%	91.07%	186.34%

Source: S&P Global Market Intelligence.